Integra LifeSciences Holdings Corp Stock
We can see a decrease in the price for Integra LifeSciences Holdings Corp. Compared to yesterday it has lost -€0.200 (-1.320%).
Currently there is a rather negative sentiment for Integra LifeSciences Holdings Corp with 0 Buy predictions and 5 Sell predictions..
A potential of -39.6%, resulting from comparing the current price of 14.9 € with the target price of 9 € for Integra LifeSciences Holdings Corp, shows the chance of incurring significant losses.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | -1.320% | -3.521% | 50.549% | 20.175% | 29.245% | -62.155% | -75.315% |
| Haemonetics Corp. | 2.480% | 4.310% | 27.637% | - | -11.679% | - | - |
| Bio-Rad Labs Inc. A | -2.640% | 3.054% | 10.310% | 35.565% | 2.055% | -24.281% | -45.167% |
| CONMED Corp. | 0.670% | -5.960% | -7.792% | -42.742% | -18.857% | -75.304% | -73.945% |
Comments
Integra LifeSciences (IART) had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (IART) had its price target lowered by Citigroup Inc. from $11.00 to $9.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
News
Integra Resources Q1 Earnings Call Highlights
Integra Resources (NYSEAMERICAN:ITRG) reported first-quarter 2026 results that management said reflected a deliberate reinvestment phase at its Florida Canyon mine, alongside continued permitting
